Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Search
Medicines Law & Policy
Research and resources on intellectual property and health
Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Tag: Medicines Patent Pool
New WHO-UNITAID briefing paper: Improving Access to Covid-19 Treatments
Kaitlin Mara
-
April 12, 2023
Wrapping up 2022 with some noteworthy medicines, law and policy events
Medicines Law & Policy
-
December 22, 2022
Wrapping up 2021 – some noteworthy medicines law and policy events
Ellen 't Hoen
-
December 24, 2021
The WHO Covid-19 Technology Access Pool signs first licence agreement; will...
Kaitlin Mara
-
November 23, 2021
A second Covid-19 treatment will now be made available through the...
Medicines Law & Policy
-
November 16, 2021
Medicines Patent Pool signs first Covid-19 licence agreement with Merck Sharp...
Medicines Law & Policy
-
October 27, 2021
Wrapping up 2020 with some noteworthy medicines, law and policy events
Medicines Law & Policy
-
December 29, 2020
Price, profit and the Covid-19 health technology pool: The example of...
Christopher Garrison
-
May 28, 2020
The € 7.4 billion for Covid-19 product and vaccine development needs...
Ellen 't Hoen
-
May 5, 2020
Covid-19 intellectual property pool gaining support
Ellen 't Hoen
-
April 23, 2020
1
2
Page 1 of 2
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
Ok
This work is licensed under Creative Commons.